Brainstorm Cell Therapeutics reported $122K in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Biogen USD 1.79B 76.6M Mar/2026
Brainstorm Cell Therapeutics USD 122K 36K Mar/2026
Cipla INR 62.19B 12.42B Mar/2026
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.34M 44K Mar/2026
CSL USD 4.32B 1.35B Dec/2025
Cytokinetics USD 6.83M 10.94M Mar/2026
Gilead Sciences USD 5.06B 314M Jun/2026
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 453.33M 4.66M Jun/2026
Mesoblast USD 43.3M 28.43M Dec/2025